Back to today’s briefing

Story perspectives

Nyxoah's Genio® System Set to Transform Sleep Apnea Care

8/10/2025

23 2

Summary

Story summary

Nyxoah, a trailblazing Belgian medical tech company, is poised to revolutionize the obstructive sleep apnea landscape with its groundbreaking Genio® system. This FDA-approved, battery-free hypoglossal nerve stimulator not only boosts patient compliance but also cuts costs. With a booming $4 billion U.S. market and encouraging clinical outcomes, Nyxoah is on track to seize a substantial share by 2030.

1 of 1

Story summary

Nyxoah, a trailblazing Belgian medical tech company, is poised to revolutionize the obstructive sleep apnea landscape with its groundbreaking Genio® system. This FDA-approved, battery-free hypoglossal nerve stimulator not only boosts patient compliance but also cuts costs. With a booming $4 billion U.S. market and encouraging clinical outcomes, Nyxoah is on track to seize a substantial share by 2030.